Shun Li Selected Research

Reperfusion Injury

1/2017	Corrigendum to "Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation".
11/2015	Intestinal mucosal injury induced by tryptase-activated protease-activated receptor 2 requires β-arrestin-2 in vitro.
1/2015	Propofol Attenuates Small Intestinal Ischemia Reperfusion Injury through Inhibiting NADPH Oxidase Mediated Mast Cell Activation.
11/2014	Pivotal role of mast cell carboxypeptidase A in mediating protection against small intestinal ischemia-reperfusion injury in rats after ischemic preconditioning.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shun Li Research Topics

Disease

96	Neoplasms (Cancer) 04/2024 - 03/2004
29	Infections 04/2024 - 01/2012
21	Breast Neoplasms (Breast Cancer) 10/2023 - 07/2015
19	Neoplasm Metastasis (Metastasis) 01/2024 - 03/2004
15	Viremia 04/2024 - 01/2012
15	Virus Diseases (Viral Diseases) 02/2024 - 01/2012
9	Glioma (Gliomas) 01/2024 - 11/2013
9	Ischemic Stroke 02/2021 - 12/2018
8	Stroke (Strokes) 01/2021 - 01/2019
6	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 01/2019
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2017
6	Carcinogenesis 05/2022 - 12/2015
5	COVID-19 12/2023 - 01/2021
5	Hypoxia (Hypoxemia) 11/2023 - 07/2014
5	Carcinoma (Carcinomatosis) 01/2022 - 12/2009
4	Pain (Aches) 04/2024 - 10/2013
4	Inflammation (Inflammations) 03/2024 - 05/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
4	Reperfusion Injury 01/2017 - 11/2014
3	Lung Neoplasms (Lung Cancer) 02/2024 - 08/2021
3	Necrosis 12/2023 - 04/2016
3	Bites and Stings (Sting) 11/2023 - 01/2023
3	Atherosclerosis 03/2023 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2018
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 11/2018
3	Type 2 Diabetes Mellitus (MODY) 05/2022 - 04/2007
3	Triple Negative Breast Neoplasms 01/2022 - 01/2020
3	Schistosomiasis japonica 01/2022 - 12/2020
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 02/2021 - 12/2018
3	Glioblastoma (Glioblastoma Multiforme) 12/2019 - 12/2015
2	Intervertebral Disc Displacement (Herniated Disc) 01/2024 - 10/2018
2	Schistosomiasis (Bilharziasis) 09/2023 - 01/2022
2	Myocardial Ischemia (Ischemic Heart Diseases) 03/2023 - 01/2022
2	Hyperthermia 02/2023 - 10/2021

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2015
17	Antiviral Agents (Antivirals)IBA 11/2023 - 01/2012
13	InterferonsIBA 12/2023 - 01/2012
12	Poly I-CIBA 04/2024 - 01/2012
9	CytokinesIBA 03/2024 - 02/2012
9	Caveolin 1IBA 11/2022 - 03/2016
8	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2004
7	Small Interfering RNA (siRNA)IBA 11/2022 - 01/2017
6	LigandsIBA 01/2024 - 11/2013
6	RNA (Ribonucleic Acid)IBA 11/2023 - 12/2020
6	Transcription Factors (Transcription Factor)IBA 07/2023 - 10/2016
5	Adenosine Triphosphate (ATP)IBA 01/2024 - 01/2017
5	LipidsIBA 01/2024 - 09/2019
5	Photosensitizing Agents (Photosensitizers)IBA 02/2023 - 01/2017
5	Messenger RNA (mRNA)IBA 12/2022 - 01/2016
5	Therapeutic UsesIBA 12/2022 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2013
4	Interleukin-6 (Interleukin 6)IBA 08/2023 - 02/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2023 - 04/2016
4	Glutathione (Reduced Glutathione)IBA 02/2023 - 01/2019
4	Silicon Dioxide (Silica)FDA LinkGeneric 02/2023 - 05/2017
4	EnzymesIBA 01/2023 - 01/2017
4	AcidsIBA 01/2023 - 01/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2019
4	Long Noncoding RNAIBA 12/2022 - 10/2021
4	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2020
4	Phosphotransferases (Kinase)IBA 01/2022 - 12/2016
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 07/2015
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2020 - 01/2012
3	polyacrylamideIBA 10/2023 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023 - 10/2015
3	MicellesIBA 10/2022 - 01/2019
3	Peptides (Polypeptides)IBA 09/2022 - 01/2021
3	Singlet OxygenIBA 09/2022 - 05/2017
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 01/2017
3	CopperIBA 05/2022 - 01/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 01/2012
3	IntegrinsIBA 01/2020 - 07/2018
3	GraphiteIBA 01/2020 - 01/2017
3	Angiopep-2IBA 12/2019 - 11/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 12/2019
2	Sorafenib (BAY 43-9006)FDA Link 12/2023 - 03/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 07/2023
2	Biocompatible Materials (Biomaterials)IBA 11/2023 - 04/2023
2	GTP Phosphohydrolases (GTPases)IBA 07/2023 - 01/2020
2	SolutionsIBA 04/2023 - 07/2020
2	FibrinIBA 03/2023 - 01/2021
2	NanovaccinesIBA 03/2023 - 10/2022
2	AntioxidantsIBA 02/2023 - 01/2017
2	Methylene Blue (Methylthioninium Chloride)FDA Link 02/2023 - 01/2022
2	Viral ProteinsIBA 02/2023 - 07/2020
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 10/2022
2	Beclin-1IBA 01/2023 - 11/2018

Therapy/Procedure

42	Therapeutics 04/2024 - 01/2017
13	Immunotherapy 01/2024 - 02/2018
12	Drug Therapy (Chemotherapy) 01/2024 - 10/2016
10	Precision Medicine 12/2022 - 01/2017
8	Thrombectomy 02/2021 - 12/2018
7	Lasers (Laser) 09/2022 - 01/2017
6	Photothermal Therapy 02/2023 - 01/2017
5	Radiotherapy 01/2024 - 10/2016
4	Photochemotherapy (Photodynamic Therapy) 02/2023 - 05/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2024 - 08/2023
2	Diskectomy (Discectomy) 01/2024 - 10/2018
2	Radiofrequency Ablation 11/2023 - 01/2022